Cytosolic phospholipase A2 as a mediator of disease pathogenesis

Cellular Microbiology
Amanda Linkous, Eugenia M Yazlovitskaya

Abstract

As efficient catalysts, enzymes help maintain a variety of biological and chemical transformations necessary for cellular metabolism and normal physiology. Unfortunately, pathogenic microbes can also exploit enzymatic reactions in an attempt to spread infection. Cytosolic phospholipase A2 (cPLA(2) ) is an enzyme that is responsible for the hydrolysis of membrane phospholipids such as phosphatidylcholine. Following activation, cPLA(2) cleaves phosphatidylcholine to yield free fatty acid and lysophosphatidylcholine. Both of these products and their downstream metabolites initiate a network of signalling cascades that influence cellular viability and inflammation. Recent observations have shown that viral and bacterial agents often target this intricate organization of signalling molecules. This review briefly discusses the role of cPLA(2) in the biological response to disease-causing pathogens and injury, the immunological process and tumour progression.

References

Oct 1, 1987·Neurochemical Pathology·A A FarooquiL A Horrocks
Jan 1, 1985·Central Nervous System Trauma : Journal of the American Paralysis Association·L A HorrocksD K Anderson
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·D ShweikiE Keshet
Jun 2, 1995·The Journal of Biological Chemistry·A P LevyM A Goldberg
Jan 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·N MartiniR J Ginsberg
Feb 1, 1994·The Journal of Clinical Investigation·J J PerdomoP J Sansonetti
Aug 1, 1994·The Journal of Experimental Medicine·A Haimovitz-FriedmanR N Kolesnick
Jan 24, 1998·The Journal of Biological Chemistry·S H BaekJ D Lambeth
Dec 1, 1998·Journal of Neurochemistry·P KlivenyiJ V Bonventre
Apr 24, 1999·Journal of the American Society of Nephrology : JASN·J V Bonventre
Jun 7, 2000·Lancet·P C HoffmanE E Vokes
Mar 23, 2001·Nature Immunology·R S HotchkissI E Karl
Jun 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L DuanH G Remold
Feb 26, 2003·Radiation Research·Paul DentRupert Schmidt-Ullrich
May 14, 2003·Cellular Signalling·Sajal Chakraborti
May 14, 2003·The Journal of Experimental Medicine·Martin HegenJames D Clark
Mar 25, 2004·Journal of Cellular Physiology·Christina Ivins ZitoAnton M Bennett
Jun 29, 2004·Journal of Virology·Cuider AllalJean-Luc Davignon
Aug 12, 2004·Biological & Pharmaceutical Bulletin·Tetsuya HirabayashiTakao Shimizu
Nov 8, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Bryan P HurleyBeth A McCormick
Nov 29, 2005·Cellular Microbiology·A M SalibaM C Plotkowski
Jan 24, 2006·Infection and Immunity·Susanne Kirschnek, Erich Gulbins
Feb 14, 2006·Critical Care : the Official Journal of the Critical Care Forum·Sheldon Magder
Apr 20, 2006·Microbiology·Taghrid S Istivan, Peter J Coloe
Oct 21, 2006·Biochimica Et Biophysica Acta·Masako Nakanishi, Daniel W Rosenberg
Nov 23, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christopher E JenkinsTong-Jun Lin
Mar 17, 2007·Molecular Cancer Therapeutics·Kristoffer ValeriePaul Dent
Mar 14, 2008·The New England Journal of Medicine·Malcolm V BrockJames G Herman

❮ Previous
Next ❯

Citations

Oct 1, 2013·Biochemical Pharmacology·Gabriella LupoClaudio Bucolo
May 28, 2013·The Cancer Journal·Andrei LaszloDennis E Hallahan
Mar 30, 2012·PLoS Pathogens·Rushika PereraRichard J Kuhn
Jun 8, 2011·Future Medicinal Chemistry·Jeffrey M Craft, Dennis Hallahan
Mar 15, 2011·Cancer Letters·Rachael R SchulteEugenia M Yazlovitskaya
Feb 18, 2014·Journal of Magnetic Resonance Imaging : JMRI·Morteza EsmaeiliArend Heerschap
Jun 30, 2012·The International Journal of Biochemistry & Cell Biology·Pratima TripathiAyyalusamy Ramamoorthy
Mar 18, 2015·American Journal of Respiratory Cell and Molecular Biology·Carmen PrioloElizabeth P Henske
Dec 2, 2014·International Journal of Medical Microbiology : IJMM·Cecilia AmbrosiMauro Nicoletti
Jan 7, 2015·Osong Public Health and Research Perspectives·Seungwoo KimJae-Pil Jeon
Apr 20, 2017·Frontiers in Pharmacology·Carmelina D AnfusoClaudio Bucolo
Apr 4, 2013·Journal of Lipid Research·Justin S BickfordHarry S Nick
Mar 1, 2012·The Journal of Pharmacology and Experimental Therapeutics·Christina L JonesElizabeth A Cowley
Jun 11, 2020·International Journal of Molecular Sciences·Sathyen A PrabhuSonia V Del Rincón
May 29, 2021·Frontiers in Physiology·Israel Pérez-TorresMaría Elena Soto
Apr 1, 2011·Bioorganic & Medicinal Chemistry Letters·Antonio MeteW John Withnall

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cell Death and Differentiation
Eugenia M YazlovitskayaDennis E Hallahan
Journal of the National Cancer Institute
Amanda LinkousDennis E Hallahan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Amanda LinkousEugenia M Yazlovitskaya
© 2021 Meta ULC. All rights reserved